Sun Pharmaceutical Industries Limited (BOM:524715)
India flag India · Delayed Price · Currency is INR
1,935.25
-3.60 (-0.19%)
At close: Jul 10, 2026

BOM:524715 Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
97,705102,68892,85746,23745,083
Short-Term Investments
44,33050,96653,71260,04144,695
Trading Asset Securities
193,131107,57344,33245,02236,771
Cash & Short-Term Investments
335,166261,227190,901151,300126,548
Cash Growth
28.30%36.84%26.17%19.56%32.33%
Accounts Receivable
155,097130,610112,602114,568105,035
Other Receivables
3,6644,9136,1884,1363,509
Receivables
159,288136,007119,440119,117110,243
Inventory
120,585107,593102,949109,68392,392
Prepaid Expenses
4,5893,7504,1353,7182,862
Other Current Assets
19,28417,66717,32515,01516,601
Total Current Assets
638,912526,245434,750398,833348,646
Property, Plant & Equipment
124,948112,703113,001113,537111,689
Long-Term Investments
37,89146,97764,41254,51749,592
Goodwill
98,33189,39485,69083,58065,913
Other Intangible Assets
135,46290,20587,33093,26861,918
Long-Term Accounts Receivable
---108.3193.7
Long-Term Deferred Tax Assets
40,46544,07641,03735,18928,496
Other Long-Term Assets
11,82711,37828,76928,39631,623
Total Assets
1,087,852921,006854,997807,436698,078
Accounts Payable
73,33861,84356,53356,81544,898
Accrued Expenses
25,24218,85616,88915,12714,833
Short-Term Debt
40,50418,67128,44459,5834,685
Current Portion of Long-Term Debt
---2,3962,323
Current Portion of Leases
1,8411,3681,2571,2811,078
Current Income Taxes Payable
13,5007,3324,1173,0871,756
Current Unearned Revenue
2,9571,3441,2651,5671,930
Other Current Liabilities
68,83972,52861,33959,214100,582
Total Current Liabilities
226,220181,942169,844199,070172,085
Long-Term Debt
312.625.213.3-2,299
Long-Term Leases
3,6163,5573,0235,5992,518
Long-Term Unearned Revenue
3,4803,7674,8875,6996,188
Pension & Post-Retirement Benefits
5,0274,5353,9973,2623,434
Long-Term Deferred Tax Liabilities
3,7801,9241,719316.9318.6
Other Long-Term Liabilities
6,618395.2253.7334.6575.4
Total Liabilities
249,055196,146183,737214,281187,417
Common Stock
2,3992,3992,3992,3992,399
Additional Paid-In Capital
11,87411,87411,87411,87411,874
Retained Earnings
694,677614,525537,452472,009412,363
Comprehensive Income & Other
126,75193,38284,94273,67153,476
Total Common Equity
835,701722,180636,668559,954480,112
Minority Interest
3,0972,67934,59233,20130,549
Shareholders' Equity
838,797724,860671,259593,155510,661
Total Liabilities & Equity
1,087,852921,006854,997807,436698,078
Total Debt
46,27323,62232,73768,85912,903
Net Cash (Debt)
288,893237,605158,16482,441113,645
Net Cash Growth
21.58%50.23%91.85%-27.46%99.57%
Net Cash Per Share
120.4199.0365.9234.3647.37
Filing Date Shares Outstanding
2,3992,3992,3992,3992,399
Total Common Shares Outstanding
2,3992,3992,3992,3992,399
Working Capital
412,692344,303264,906199,763176,562
Book Value Per Share
348.31300.99265.35233.38200.10
Tangible Book Value
601,909542,581463,648383,105352,282
Tangible Book Value Per Share
250.86226.14193.24159.67146.82
Land
8,2667,8568,1736,6766,448
Buildings
74,41565,32563,61061,39557,836
Machinery
169,555152,025146,265139,645132,031
Construction In Progress
13,80712,34311,0779,6347,975